SANUWAVE Health, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
SANUWAVE Health, Inc. (SNWV) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$5.59 million for the 3-month period ending 2020-09-30, per its 10-Q/A filed 2021-07-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2021-07-01
- SANUWAVE Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2020-09-30 was -$5.59M.
- SANUWAVE Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2019-09-30 was $0.00.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month |
|---|---|---|
| 2020-09-30 | -$5.59M 10-Q/A · filed 2021-07-01 | -$5.59M 10-Q/A · filed 2021-07-01 |
| 2019-09-30 | $0.00 10-Q/A · filed 2021-07-01 | $227.67K 10-Q/A · filed 2021-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |